We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Glenmark Gets the FDA’s Nod for Generic Mavik Tabs
Glenmark Gets the FDA’s Nod for Generic Mavik Tabs
June 27, 2008
Glenmark Generics, a subsidiary of Indian drugmaker Glenmark, has received FDA approval for its ANDA to market a generic version of Abbott Laboratories’ blood pressure drug Mavik in 1-, 2- and 4-mg strengths.